Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’

COVID-19 and rheumatology: first steps towards a different future?

(2020) Iain B McInnes   ANNALS OF THE RHEUMATIC DISEASES

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

(2020) Sara Monti et al.   ANNALS OF THE RHEUMATIC DISEASES

Festina lente: hydroxychloroquine, covid-19 and the role of the rheumatologist

(2020) Elizabeth R Graef et al.   ANNALS OF THE RHEUMATIC DISEASES

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

(2020) Wen Zhang et al.   CLINICAL IMMUNOLOGY

What we know so far: COVID-19 current clinical knowledge and research

(2020) Mary A Lake   CLINICAL MEDICINE

COVID-19 and African Americans

(2020) Clyde W. Yancy   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Tocilizumab treatment in COVID-19: A single center experience

(2020) Pan Luo et al.   JOURNAL OF MEDICAL VIROLOGY

COVID-19 exacerbating inequalities in the US

(2020) Aaron van Dorn et al.   LANCET

Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York

(2020) Rebecca Haberman et al.   NEW ENGLAND JOURNAL OF MEDICINE

American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID‐19 Pandemic

(2020) Ted R. Mikuls et al.   Arthritis & Rheumatology

Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission

(2018) David S Hui et al.   LANCET INFECTIOUS DISEASES

Viral infections in the biologic therapy era

(2018) Ivan Noreña et al.   Expert Review of Anti-Infective Therapy

The Effect of Statin Use on Mortality in Systemic Autoimmune Rheumatic Diseases

(2018) April M. Jorge et al.   JOURNAL OF RHEUMATOLOGY